Fat Grafting for Treatment of Facial Scleroderma - 18/11/19
Résumé |
Reparative, angiogenic, and immunomodulatory properties have been attributed to the cells in the adipose tissue–derived stromal vascular fraction. Because of these characteristics, in the last decade, fat grafting for treatment of autoimmune diseases has grown. This article focuses on systemic sclerosis, a rare autoimmune disease characterized by skin fibrosis and microvascular damage. Lesions of the face are almost always present; however, current therapy is insufficient and patients have considerable disability and social discomfort. This article presents our approach to using fat grafting in the face as an innovative and promising therapy for patients with systemic sclerosis.
Le texte complet de cet article est disponible en PDF.Keywords : Systemic sclerosis, Cell therapy, Microfat injection, Nanofat, Platelet-rich plasma, Stromal vascular fraction, Fat grafting, Adipose tissue
Plan
A. Daumas and J. Magalon contributed equally to this work. |
|
Disclosure: G. Magalon is a consultant for the Thiebaud Medical Device, and received financial grants and other support for research and honorarium as a consultant. The other authors have nothing to disclose. |
Vol 47 - N° 1
P. 155-163 - janvier 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?